HEAPHY 1 & 2 CASE RACE 2 – RT Jemma HURLEY Sat 31 st Aug 2013 Session 3 / CR2-4 13:51 – 13:55 CANTERBURY / WESTLAND ABSTRACT This case follows the Radiation.

Slides:



Advertisements
Similar presentations
FACET - European Journal of Cancer Care March 2006 slides available at: Stereotactic radiosurgery Gordon, K. 1.
Advertisements

Clival Chordoma Case in Pediatric Patient
Oncology management of CNS tumours Neil Burnet University of Cambridge Department of Oncology & Oncology Centre, Addenbrookes Hospital ECRIC CNS study.
A phase I dose escalating study of intensity modulated radiation therapy (IMRT) for the treatment of glioblastoma multiforme (GBM) ( #1008) V. Stieber.
Medicare Transmittal 956 CR 5124 May 19, 2006 NOPR Billing Instruction Clarification – Physician Offices/IDTF use QR Modifier – Hospitals use QR and V70.7.
History of the randomized evidence on early breast cancer overall survival: Radiation vs no radiation after mastectomy L. Vakaet 2006.
Controversies in Adjuvant Therapy for Pancreatic Cancer Parag Sanghvi M.D. Tasha McDonald M.D. Department of Radiation Medicine OHSU.
Do you know what ’ s in people ’ s head?. Brain tumors 72 male 72 male HPI: presents to E.R. with history of confusion, change of personality, left sided.
Journal club Dr Eyad Al-Saeed Radiation Oncology 8-Sep-2007.
Radiotherapy for Brain Tumours What do I need to know? Dr Matthew Foote Radiation Oncologist Princess Alexandra Hospital Queensland.
Managing the patients experience of radical surgery with HIPEC for stage 4 colorectal disease Jackie Rodger Lead Colorectal Nurse Specialist Carol Baird.
Brain Tumours – what should I know?
Session 1 (tutorial session): Radiation and Thyroid Cancer Summary Many patients with thyroid cancer were found in the Fukushima Health Management survey.
Sequential vs. concurrent chemoradiotherapy for locally advanced non-small cell carcinoma.
ODAC SCHERING-PLOUGH RESEARCH INSTITUTE 1 Temozolomide Oncology Drug Advisory Committee March 13, 2003 Craig L. Tendler, M.D. Vice President, Oncology.
HEAPHY 1 & 2 CASE RACE 2 – RT Anna RIDLEY Sat 31 st Aug 2013 Session 3 / CR2-1 13:36 – 13:40 WAIKATO / BAY OF PLENTY ABSTRACT An investigation into the.
TREATMENT PLANNING Modelling chemo-hadron therapy Lara Barazzuol | Valencia | 19 June 2009.
ICNCT-16, , Helsinki, Finland
HEAPHY 1 & 2 CASE RACE 2 – RT Tony FALLON Sat 31 st Aug 2013 Session 3 / CR2-2 13:41 – 13:45 CANTERBURY / WESTLAND ABSTRACT This case race presents the.
Timeliness of Cancer Registry Reporting Ali Johnson, CTR Vermont Cancer Registry Vermont Explor Annual Data Meeting May 1, 2006.
HEAPHY 1 & 2 CASE RACE 1 – DIAG Sharyn BRAY Sat 31 st Aug 2013 Session 3 / CR1-3 13:11 – 13:15 CENTRAL ABSTRACT Working at a Massey University Vet Hospital.
PROSTATE CANCER: RADIATION APPROACHES for advanced disease
Image-Guided Adaptive Therapy for the Treatment of Lung Cancer
Anal Cancer - Case 1  62 years old woman with 6 months history of anal pain  Clinically T 3 squamous cell carcinoma growing anteriorly  Which staging.
Irradiation of stem cell niches in the periventricular and sub granular zones in gbm : A Prospective study Akram K S, Monica I, Deepa J, Kesava R, Fayaz.
NYU Medical Grand Rounds Clinical Vignette Rachel Shur PGY-2 October 16, 2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Treatment Regimens of HER2+ Adjuvant Patients (Actuals) Source: Genentech ASCO 2005 (data release) Nov 2006 (Approval)
GBM – Oncological Management Dr H Lord Consultant Clinical Oncologist.
Principal Author, MD Second Author, MD PhD Third Author, MSc Institution, City, Country 23 January 2013.
P53 adapted neoadjuvant therapy for esophageal cancer: Pilot study Gastrointestinal (Non colorectal) cancer Poster discussion session Sat, June 2, 2007.
HEAPHY 1 & 2 CASE RACE 1 – DIAG Yvonne CLARKE Sat 31 st Aug 2013 Session 3 / CR1-4 13:16 – 13:20 WELLINGTON ABSTRACT Following a woman’s pathway from her.
This is an example text TIMELINE PROJECT PLANNING DecOctSepAugJulyJuneAprilMarchFebJanMayNov 12 Months Example text Go ahead and replace it with your own.
M ETHODS Median dose was 22Gy (range: ) in 1 to 5 fractions Median treatment volume was 12.6 cc (range: ). Assessed for eligibility.
Journal Club Dr. Eyad Al-Saeed Radiation Oncology 12 January, 2008.
HEAPHY 1 & 2 CASE RACE 1 – DIAG Heather GUNN Sat 31 st Aug 2013 Session 3 / CR1-1 13:01 – 13:05 AUCKLAND ABSTRACT Auckland will present an interesting.
Early Treatment of Relapsed Ovarian Cancer Based on CA125 Level Alone Versus Delayed Treatment Based on Conventional Clinical Indicators Results of the.
Use of Bevacizumab in anticoagulated recurrent glioblastoma multiforme patients: An Australian experience Adrian Lee 1,2,3,4, Marina Kastelan 4,5, Helen.
SARC018: A SARC PILOT MULTICENTER STUDY OF PREOPERATIVE RADIATION AND SURGERY IN PATIENTS WITH HIGH- RISK DESMOID TUMORS Robert S. Benjamin, M.D.
Evaluating the Clinical Outcomes of Sixty-Three Patients Treated with Gamma Knife as Salvage Therapy for Glioblastoma Multiforme Erik W Larson, Halloran.
Short-term outcome of neo-adjuvant chemotherapy
Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis.
Brain Tumours – what should I know?
Ari Brooks, MD Cancer Surgeon, Big Data End User
Results of Definitive Radiotherapy in Anal Canal Carcinoma
Split-Course Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Single-Institution Experience of 144 Patients  Benjamin T. Gielda, MD,
Feasibility of hippocampal sparing radiation therapy for glioblastoma using helical Tomotherapy Dr Kamalram THIPPU JAYAPRAKASH1,2,3, Dr Raj JENA1,4 and.
Post-operative therapy for G2 and G3 Gliomas
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
Dose–Volume Relationships Associated With Temporal Lobe Radiation Necrosis After Skull Base Proton Beam Therapy  Mark W. McDonald, MD, Okechukwu R. Linton,
Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases  Isabelle Thibault, MD, Mikki Campbell,
IMRT delivery of preoperative, high dose radiotherapy to a large volume, with Simultaneous Integrated Boost (SIB) in retroperitoneal sarcomas: The Ottawa.
Percutaneous Cryoablation of Metastatic Ovarian Cancer for Local Tumor Control: Improved Patient Survival and Estimated Cost-Effectiveness Brandt P. Currier.
Improving Survival in Glioblastoma Multiforme
Prostate Cancer: Highlights from 2006
Should we irradiate a brain tumor in a patient with parkinsonism
Split-Course Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Single-Institution Experience of 144 Patients  Benjamin T. Gielda, MD,
ACOSOG Clinical Trials
Extraordinary Cases of VTE Prevention in Patients With Cancer
Should we irradiate a brain tumor in a patient with parkinsonism
ACT II: The Second UK Phase III Anal Cancer Trial
2009 TIMELINE PROJECT PLANNING 12 Months Example text Jan Feb March
Volume 383, Issue 9935, Pages (June 2014)
PLANNING LOOKING AHEAD…. Long Term Goals (Assigned to…)
Nicholas Trakul, MD, PhD, Jeremy P
39/69 hormone replacement 9/69 Cerebrovascular events
Todd J. Carpenter, MD, Kenneth E. Rosenzweig, MD 
2009 TIMELINE PROJECT PLANNING 12 Months Example text Jan Feb March
Protracted temozolomide (TMZ) treatment leads to acquired TMZ resistance in glioblastoma (GBM) cells in vivo. Protracted temozolomide (TMZ) treatment leads.
Results: Purpose/Objectives: Methods: Conclusions:
Presentation transcript:

HEAPHY 1 & 2 CASE RACE 2 – RT Jemma HURLEY Sat 31 st Aug 2013 Session 3 / CR2-4 13:51 – 13:55 CANTERBURY / WESTLAND ABSTRACT This case follows the Radiation Treatment Planning process for a recurrent Glioblastoma Multiforme Brain patient. This patient received two courses of RT to the same site resulting in a total dose of 100Gy to the brain. Interesting points to be covered include patient history, RO prescription choice and associated evidence, planning process and patient implications. This case study will be focused on planning rather than treatment.

Jemma Hurley Radiation Therapist Canterbury District Health Board

Patient Information  58 year old Female  Diagnosis: Glioblastoma Multiforme  Site: Left Brain

Patient History  May 2011: Surgical debulking GBM  June 2011: Commenced Radiation Therapy concurrent w Temozolomide  July 2011: Completed RT  Jan 2012: Completed 6 th cycle Temozolomide  Nov 2012: Recurrent dysphagia & headaches  Dec 2012: Debulking  recurrent GBM commenced PCV chemo  March 2013: MRI  progression  May 2013: Commenced Course 2 Radiation Therapy

Prescription  Course 1: 60Gy/30# to Left Brain  Course 2: 40Gy/20# to Left Brain  Total Dose to Left Brain = 100Gy

Planning Principles

Volumes  Location of tumour made 100Gy possible  Screen dump

Course 1

Course 2

Composite C1/C2

DVHs composite plan

Patient Implications  Brain Necrosis Only significant after 100Gy Brain can recover  Benefit versus Risk  Survival Further 5 months

References  Short SC. Re-irradiation of brain tumours – evidence, indications and limitations. European journal of cancer